EDOW First Trust Dow 30 Equal Weight ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| CVX | 3.81% |
| MRK | 3.53% |
| WMT | 3.47% |
| JNJ | 3.46% |
| VZ | 3.45% |
| JPM | 3.43% |
| CSCO | 3.42% |
| KO | 3.41% |
| SHW | 3.40% |
| GS | 3.40% |
ETF Analysis
Fund Overview
First Trust Dow 30 Equal Weight ETF (EDOW) currently reports 31 stock positions (subject to change), placing it in the diversified without being diffuse range by holdings breadth. The top line-up is CVX (3.81%), MRK (3.53%), WMT (3.47%), with CVX as the largest single weight at 3.81%. Together, the top three holdings account for 10.81%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 22.11%, WACC is 8.05%, and the economic spread is 14.06%. On balance, ROIC clears WACC by a meaningful margin, suggesting the portfolio's holdings are creating rather than consuming intrinsic value. Supporting metrics show ROE at 50.15% and ROA at 9.31%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
From a pricing standpoint, the portfolio sits at trailing P/E of 22.76, forward P/E of 19.49, PEG of 3.12. The narrow spread between trailing and forward multiples implies earnings expectations are relatively stable — the portfolio is not being priced for an earnings inflection. A PEG above 2.5 implies investors are paying well above fair value for the growth embedded in estimates — a setup that typically leaves little room for earnings disappointment. A current ratio of 1.21 signals that short-term coverage is tighter than typical across the holding set. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 52.36%, operating margin at 23.46%, and free cash flow margin at 17.55%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. At this FCF margin level, the underlying holdings demonstrate good cash generation relative to the revenue base. Together, these margin readings describe a portfolio of businesses that protect profitability at every layer of the income statement.
Growth & Forward Outlook
Connecting operational trends with market expectations, TTM revenue growth of 10.57% indicating steady top-line growth at the portfolio level, while the estimated 12-month price change of 18.32%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 16.8%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyOverall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.